Pillstats
Rx only · Injection, Solution · Subcutaneous

Methotrexate

Brands: Otrexup · Rasuvo · Methotrexate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US16 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01BA01
RxCUI (US)6851
US makers2 labelers
Packages39
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$182.20$364.39$546.59$728.79Apr 2025Jan 2026Apr 2026
$523.948
Latest avg · Apr 1, 2026
-17%
Since Apr 1, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.4K4.9K7.3K9.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
7.5K
Rx · 2026 Q1
13K
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Medexus Pharma Inc.unknown18SUPPLYING
Antares Pharma, Inc.unknown21EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.